Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat and iron metabolism in peritoneal dialysis patients
ChiCTR2200057231Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of roxadustat and erythropoietin in Uraemic Anaemia (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoints: Hepcidin, Serum soluble transferrin receptor and 2 more. Started Mar 2022; status: recruiting.
02
Drugs
roxadustaterythropoietin
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on ChiCTR2200057231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057231.